Immunovant, Inc. - Common Stock, par value $0.0001 per share (IMVT)

183 filings reported holding IMVT - Immunovant, Inc. - Common Stock, par value $0.0001 per share as of Q2 2023.
Immunovant, Inc. - Common Stock, par value $0.0001 per share (IMVT) has 145 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 55,460,743 shares of 202,731,676 outstanding shares and own 27% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (5,468,616 shares), Deep Track Capital, LP (5,421,330 shares), FMR LLC (5,253,868 shares), BlackRock Inc. (4,201,314 shares), STATE STREET CORP (3,234,169 shares), PERCEPTIVE ADVISORS LLC (2,523,783 shares), Logos Global Management LP (2,250,000 shares), Avidity Partners Management LP (2,085,000 shares), Redmile Group, LLC (1,921,152 shares), and Alpine Global Management, LLC (1,439,544 shares).
This table shows the top 145 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.